Claus G. Roehrborn mostly deals with Urology, Lower urinary tract symptoms, Surgery, Prostate and Placebo. His biological study spans a wide range of topics, including Prostate-specific antigen, Prostate cancer, Randomized controlled trial and Gynecology. Claus G. Roehrborn has researched Lower urinary tract symptoms in several fields, including Tadalafil, Erectile dysfunction and Urinary system.
His work in Surgery tackles topics such as Nomogram which are related to areas like Logistic regression. The concepts of his Prostate study are interwoven with issues in Biopsy, Predictive value of tests, Hyperplasia and Pathology. His Placebo research focuses on Nocturia and how it relates to Serenoa.
Claus G. Roehrborn spends much of his time researching Urology, Lower urinary tract symptoms, Prostate, Internal medicine and Prostate cancer. The various areas that Claus G. Roehrborn examines in his Urology study include Dutasteride, Placebo, Surgery and Hyperplasia. His work is dedicated to discovering how Lower urinary tract symptoms, Tamsulosin are connected with Combination therapy and other disciplines.
His research integrates issues of Prospective cohort study and Radiology in his study of Prostate. His studies deal with areas such as Endocrinology and Oncology as well as Internal medicine. His Prostate cancer research incorporates elements of Biopsy and Gynecology.
Claus G. Roehrborn mainly investigates Urology, Prostate, Lower urinary tract symptoms, Hyperplasia and Prostate cancer. He integrates Urology with Volume in his study. His work on Prostatectomy as part of general Prostate research is frequently linked to Likert scale, bridging the gap between disciplines.
His work in Prostatectomy addresses subjects such as Surgery, which are connected to disciplines such as Prostatic urethral lift. Claus G. Roehrborn has included themes like Randomized controlled trial, Tamsulosin and Quality of life in his Lower urinary tract symptoms study. His Prostate cancer research incorporates themes from Effective diffusion coefficient, Risk stratification and Radiation therapy.
His primary scientific interests are in Prostate, Lower urinary tract symptoms, Urology, Hyperplasia and International Prostate Symptom Score. The study incorporates disciplines such as Surgery, Cancer research and Prostate cancer in addition to Prostate. His Lower urinary tract symptoms research includes themes of Randomized controlled trial, Quality of life, Adverse effect, Sexual function and Transurethral resection of the prostate.
His studies in Urology integrate themes in fields like Local anesthesia, Internal medicine, Incidence, Catheter and Perioperative. Claus G. Roehrborn combines subjects such as Urinary retention, Cluster of differentiation, 5 Alpha-Reductase Inhibitor and Prostatic urethra with his study of Hyperplasia. His International Prostate Symptom Score study also includes fields such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
John D. McConnell;Claus G. Roehrborn;Oliver M. Bautista;Gerald L. Andriole.
The New England Journal of Medicine (2003)
Radical Prostatectomy versus Observation for Localized Prostate Cancer
Timothy J. Wilt;Michael K. Brawer;Karen M. Jones;Michael J. Barry.
The New England Journal of Medicine (2012)
The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia
John D. McConnell;Reginald Bruskewitz;Patrick Walsh;Gerald Andriole.
The New England Journal of Medicine (1998)
Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia
Kevin T. McVary;Claus G. Roehrborn;Andrew L. Avins;Michael J. Barry.
The Journal of Urology (2011)
Female Stress Urinary Incontinence Clinical Guidelines Panel Summary Report on Surgical Management of Female Stress Urinary Incontinence
Gary E. Leach;Roger R. Dmochowski;Rodney A. Appell;Jerry G. Blaivas.
The Journal of Urology (1997)
Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy
Andrew J. Stephenson;Peter T. Scardino;Michael W. Kattan;Thomas M. Pisansky.
Journal of Clinical Oncology (2007)
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
Claus G Roehrborn;Peter Boyle;J.Curtis Nickel;Klaus Hoefner.
The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study
Claus G. Roehrborn;Paul Siami;Jack Barkin;Ronaldo Damião.
European Urology (2010)
Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients
M.Craig Hall;Sean Womack;Arthur I Sagalowsky;Thomas Carmody.
Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy
Andrew J. Stephenson;Shahrokh F. Shariat;Michael J. Zelefsky;Michael W. Kattan.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: